1. Forced expiratory flow rates and specific airways conductance were measured before and after the inhalation of the atropine-like drug ipratropium bromide in 11 diabetic patients with autonomic neuropathy and a control group of 1 1 diabetic patients without autonomic neuropathy. Respiratory muscle function was assessed by recording maximal inspiratory and expiratory mouth pressures.
Introduction
1. Forced expiratory flow rates and specific airways conductance were measured before and after the inhalation of the atropine-like drug ipratropium bromide in 11 diabetic patients with autonomic neuropathy and a control group of 1 1 diabetic patients without autonomic neuropathy. Respiratory muscle function was assessed by recording maximal inspiratory and expiratory mouth pressures.
2. There was no difference between the two groups of diabetic patients in airway calibre before ipratropium bromide or in maximal mouth pressures.
3. Bronchodilatation after ipratropium bromide was greater in the control group than in the autonomic neuropathy group of patients.
4. It is concluded that, despite the lack of clinical evidence of respiratory involvement, patients with diabetic autonomic neuropathy have reduced airway vagal tone.
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Abbreviations: FEV,., forced expiratory volume in 1 s; FVC, forced vital capacity; RV, residual volume; sGaw, specific airways conductance; TLC, total lung capacity; V,,,,,. 20 FVC and V,,,,,. 50 FVC, forced expiratory flow rates at 20 and 50% respectively of vital capacity on forced vital capacity manoeuvres; Vma+ 20 P, forced expiratory flow rate on 20% of vital capacity on partial forced expiratory manoeuvres.
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Autonomic neuropathy in diabetes mellitus is characterized by postural hypotension, bladder and sexual dysfunction, gastric hold-up and altered bowel habit. Other manifestations include hypoglycaemic unawareness, disturbances of body temperature regulation and sweating abnormalities. Although involvement of the cardiovascular, gastrointestinal and urogenital systems are relatively easily demonstrated, there is no evidence of respiratory system involvement. The aim of the present study was to determine whether this is due to sparing of the respiratory autonomic nerves in diabetic autonomic neuropathy or whether, despite the lack of clinical evidence, these nerves are damaged.
While there is agreement that vagal efferents provide bronchoconstrictor tone to human airways, there is doubt as to whether there is any direct adrenergic innervation of bronchial smooth muscle [ l , 21 and also bronchodilatation may be mediated by other nerve pathways, possibly with a purinergic transmitter system t2, 31. We therefore assessed autonomic function in the airways of patients with diabetic autonomic neuropathy by blocking vagally mediated bronchoconstrictor tone with the atropine-like drug ipratropium bromide (Atrovent; Boehringer Ingelheim), which produces bronchodilatation in normal subjects [41.
Methods
We studied two groups of insulin-dependent diabetic patients matched for age, sex and duration of diabetes, 1 1 with and 1 1 without diabetic autonomic neuropathy ( Table 1) . The patients with diabetic autonomic neuropathy had two or more symptoms suggestive of autonomic neuropathy (impotence, symptoms of postural hypotension, episodic nocturnal diarrhoea, hypoglycaemic unawareness, sweating abnormalities and gastric disturbances) [S] and abnormal cardiovascular reflexes. Four simple cardiovascular autonomic function tests were used: the heart rate-response to the Valsalva manoeuvre, the lying to standing (30/15) heart rateresponses, the postural fall in blood pressure and the blood pressure-response to sustained handgrip as described previously [5,61. All 11 patients with autonomic neuropathy had abnormal responses to both the Valsalva manoeuvre and the 30/15 heart rate-response (suggesting cardiac vagal damage); five had an abnormal and one a borderline response to sustained hand-grip and seven an abnormal and three a borderline blood pressure-response to posture, suggesting additional sympathetic damage. The patients without autonomic neuropathy had no symptoms suggestive of autonomic neuropathy and normal cardiovascular reflex-responses to the four tests mentioned above. None of the patients had a history of atopy or of respiratory illness, none had respiratory symptoms as detected by the MRC questionnaire [71 and each had a normal forced expiratory volume in 1 s (FEV,.,), forced vital capacity (FVC) and FEV,.,/FVC ratio. The study had the approval of the Hospital Ethical Committee and each subject gave informed consent.
After maximal expiratory and inspiratory mouth pressures were recorded, forced expiratory flow rates and specific airways conductance were measured before and during the period 90-120 min after the inhalation of 8 0 pg of ipratropium bromide (0.10 pmol, four puffs) from a piessurized metered dose-inhaler. With the lips around the aerosol dispenser, the subject inhaled from residual volume (RV) to total lung capacity (TLC) and the researcher manually triggered the metered dose-inhaler at about functional residual capacity (FRC). Each subject held his breath at TLC for 5 s and then breathed normally for 30 s before the next inhalation of drug. Forced vital capacity manoeuvres were performed in a pressure-compensated volume-displacement body plethysmograph, l i k e d on-line to a PDP 11/40 computer. Three satisfactory FVC manoeuvres were obtained on each occasion, the vital capacities being within 150 ml on each occasion. The highest flow rates (Vmax) and expired volumes obtained were used. As well as FVC manoeuvres, partial manoeuvres were performed in which the subject breathed at his normal FRC before inhaling to about 55% of VC and then exhaling forcibly to RV. Partial manoeuvres avoid the inhibition of vagal tone which results from inhalation to TLC [81. Specific airways conductance (sGaw) was measured in a pressurecompensated-flow body plethysmograph, rebreathing at 1 Hz from a heated humidifed bag.
Maximum expiratory and inspiratory mouth pressures were also recorded in this plethysmograph, by forcibly exhaling or inhaling at a range of lung volumes against a closed shutter with a slow leak with the subject firmly holding his cheeks [9, 101. The autonomic function tests and respiratory tests were performed by different observers neither of whom had knowledge of the results of the other tests until the study was completed. The significance of changes observed was assessed by Wilcoxon's rank test for paired differences or rank-sum test [ 111.
Results
There were no significant differences between the two groups in maximal mouth pressures or in tests of baseline airways calibre (Table 2 ). In the diabetic patients without autonomic neuropathy, ipratropium bromide resulted in significant bronchodilatation (P < 0-01), as measured by all tests ( Table 2 ). In the diabetic autonomic neuropathy patients significant bronchodilatation after treatment was shown by an increase in sGaw and in the flow rates at 20% of VC during both FVC and partial manoeuvres (P < 0.05), but neither FEV,., or the flow rate at 50% of VC on FVC changed after ipratropium bromide. Ipratropium bromide produced greater increases (P < 0.05) in sGaw and flow rates at 20 and 50% of VC on FVC manoeuvres in the control group than in the patients with diabetic autonomic neuropathy (Fig. 1) . There was no difference between the two groups in the increase in FEV,., or flow rates at 20% of VC on partial manoeuvres after ipratropium bromide.
Discussion
Ipratropium bromide acted as a bronchodilator in patients without diabetic autonomic neuropathy and, as none of the changes observed were statistically different from those found in 10 normal subjects [41, these patients had normal vagal tone in their airways. However, the patients with diabetic autonomic neuropathy had reduced resting vagal bronchomotor tone in boJh their large (sGaw and V, , , , , . 50) and small (VmaX. 20 FVC) airways (Fig. 1) . Our failure to demonstrate a difference in change in FEV,., or in V,,,,,. 20 on partials probably resulted from the small and varied increases in these tests after ipratropium bromide in subjects without airways obstruction.
Our conclusion that patients with diabetic autonomic neuropathy have reduced airway vagal tone depends on 80 pg of ipratropium bromide producing maximal vagal blockade with peak effects at 90-120 min in normal subjects. These assumptions are supported by our own published [41 and unpublished observations in 20 normal subjects. We are currently seeking other evidence that patients with diabetic autonomic neuropathy have impaired bronchomotor function.
Although the patients with diabetic autonomic neuropathy had impaired airway vagal tone, we found no clinical or physiological sequelae. The biological purpose served by intrinsic smoothmuscle tone is not clear. Such tone may locally regulate ventilation to optimize ventilation/ perfusion (V/Q) relationships. However, our patient; with reduced vagal tone did not have gross VlQ mismatching as resting arterial oxygen saturation (Hewlett Packard 47201A ear oximeter) [121, which was measured in eight of the 11 patients, was always normal (95-98%). In addition, airway tone might provide rigidity to the airways, preventing collapse during rapid exhalation, but we did not find lower baseline flow rates in the patients with diabetic autonomic neuropathy with impaired airway tone. However, the baseline flow rates of the patients with diabetic autonomic neuropathy would also be influenced by bronchodilatation, also due to decreased vagal tone, and perhaps by autonomic neuropathy affecting any bronchodilator nerves. The offsetting factors plus the wide ranges for normal values [131 probably explain why there was no difference between the two groups in tests of baseline airway calibre.
Although the majority of the patients with diabetic autonomic neuropathy had both peripheral and autonomic neuropathies, there was no evidence of damage to the phrenic or intercostal nerves as respiratory muscle function was normal. Therefore respiratory muscle weakness is unlikely to contribute to the unexpected cardiorespiratory arrests which have been observed in such patients [61.
